Vaskaridou E, Konstantopoulos K, Kyriakou D, Loukopoulos D
Thalassemia Unit, Laikon Hospital, Athens, Greece.
Haematologica. 1993 May-Jun;78(3):183-4.
We report two cases of transfusion-dependent thalassemia treated by deferoxamine during the first trimesters of two successful pregnancies. The absence of any sign(s) of toxicity or teratogenicity is remarkable; despite the data from animal models, it seems that deferoxamine in humans is rather harmless for the fetus at the usually recommended doses.
